CureMetrix® receives FDA Clearance for AI-based triage software for mammography

CureMetrix® cmTriage™ helps to triage and prioritize mammography
workflow for radiologists

Our ability to bring cmTriage™ to the medical community is a major milestone in our mission to deliver CAD that Works® to support the radiologist and the patients they serve.”

— Kevin Harris, CEO, CureMetrix

LA JOLLA, CA, USA, March 19, 2019 /EINPresswire.com/ — CureMetrix®, a healthcare technology company that develops computer-aided detection (CAD) software based on artificial intelligence (AI), announced today that it has received clearance from the U.S. Food and Drug Administration to market its product cmTriage™.

CureMetrix cmTriage is a workflow optimization tool that enables a radiologist to customize, sort, and prioritize their mammography worklist based on cases that may need immediate attention. Rather than today’s method of first in, first out for reading through a screening mammography worklist, radiologists can now use cmTriage to identify which cases are suspicious and focus on those first. They can also use cmTriage to optimize their clinical workflow by sending the suspicious cases to their most senior radiologists or reading the suspicious cases immediately before the patient has even left the clinic.

CureMetrix cmTriage has an area under the curve (AUC) of 0.95. With this high level of efficacy, radiologists can expect cmTriage to highlight the suspicious cases without excessive false positives.

"Early and accurate detection in breast cancer detection is key in improving cancer survival rates worldwide through the development of next generation medical image analysis solutions. With 40 million mammograms a year in the U.S., only five cancers per 1,000 are being found at screening. cmTriage allows the radiologist to prioritize their worklist, creating the potential to help doctors move more quickly through their reviews and find those cancers by highlighting the suspicious cases.

“Our ability to bring cmTriage to the medical community is a major milestone in our mission to deliver CAD that Works® to support the radiologist and the patients they serve,” said Kevin Harris, CEO and Board Director for CureMetrix.

Said Lisa Watanabe, M.D., Chief Medical Officer at CureMetrix and Clinical Associate
Professor at University of Southern California, “Our goal is to provide radiologists with analytic tools to enhance diagnosis in breast cancer screening and augment treatment decisions.

“On average, early signs of breast cancer may be missed up to 50% of the time on mammograms. Analysis of mammograms with cmTriage has the potential to help radiologists focus on the suspicious cases and increase their productivity. This will allow for more time to engage with our patients and the healthcare team.

“Providing radiologists with the most advanced technology and tools like cmTriage to support their evaluation of mammograms will lead to improved clinical outcomes,
reduced healthcare costs and increased assurance that patients are receiving high quality and accurate clinical care.”

For FDA clearance details, visit https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K183285

About CureMetrix
Delivering CAD that Works®, CureMetrix is committed to the advancement of technology that improves cancer survival rates worldwide. With research that leverages artificial intelligence (AI) and deep learning to develop the next generation of medical image analysis, CureMetrix delivers technology that radiologists, healthcare systems and patients can confidently rely on. For more information visit www.curemetrix.com

Dawn Anderson
CureMetrix
+1 858-345-6061
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Protein Crystallization Market: Global Industry Analysis and Opportunity Assessment, 2019 – 2023

New Study On “2019-2023 Protein Crystallization Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast”

PUNE , MAHARASHTRA, INDIA, March 19, 2019 /EINPresswire.com/ — Global Protein Crystallization Industry

New Study On “2019-2023 Protein Crystallization Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

Protein crystallization is the process of formation of a protein crystal, the crystallized protein is studied for extensive information about the structure of the protein. The entire process involves several steps including preparation of the sample, purification of protein and so on, once the process is initiated the protein crystal is formed using techniques such as microbatch, vapor diffusion, and so on. The structured protein is highly demanded in drug discovery nowadays, making it one of the major factors for growth. Industries such as biotechnology and pharmaceuticals need high-resolution information on protein structure for research and development of innovative. Moreover, increased funding and support from governing bodies also contribute significantly to the market growth. The crystallization process is costly and time-consuming hinders the growth of the market. Furthermore, the growth is also limited due to the difficulty associated in handling the protein crystals due to its fragile nature and sensitiveness to temperature, pH and so on. The technological advancement especially in the method of crystallization, integration with digital technologies and growing trends of lab automation will pave the way for future growth of the market.

Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/3739563-global-protein-crystallization-market-research-and-forecast-2018-2023

The market is divided into North America, Europe, Asia-Pacific and Rest of the World. The Asia-Pacific region is expected to show exponential growth in the market attributed to the rapid development of infrastructure and investment in the healthcare sector. The North American and European region is expected to have a significant share in the market due to the presence of advance organizations and research and development facilities.

The company engaged in protein crystallization services provides protein purification, separation, and protein crystallography services. The company leverages x-ray crystallography, NMR spectroscopy and other such technologies to study the structure of protein crystals hence, helping pharmaceutical companies in drug discovery and other research works. The key players in the protein crystallization market are Creluc GmbH, GE Healthcare, Jena Bioscience GmbH, MiTeGen LLC, Molecular Dimensions Ltd., Novoprotein, Proteros biostructures GmbH, Thermo Fisher Scientific and so on. The presence of a large number of companies makes the entire market highly competitive. 

For Detailed Reading Please visit WiseGuy Reports @  https://www.wiseguyreports.com/reports/3739563-global-protein-crystallization-market-research-and-forecast-2018-2023

Research methodology 
The market study of global protein crystallization market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports. 
Secondary sources include 
• Financial reports of companies involved in the market 
• Authentic Public Databases (org, gov and other such websites) 
• Whitepapers such as research papers and news blogs 
• Company websites and their product catalog. 
The report is intended for researchers in the healthcare segment, Emerging companies and researchers in the market, investing companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions. 
Market segmentation 
1. Global Protein Crystallization Market Research and Analysis by Product Type 
2. Global Protein Crystallization Market Research and Analysis by Technology 
3. Global Protein Crystallization Market Research and Analysis by End-User 
The report covers 
• Comprehensive research methodology of the global protein crystallization market. 
• This report also includes a detailed and extensive market overview with key analyst insights. 
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. 
• Analysis of regional regulations and other government policies impacting the global protein crystallization market. 
• Insights about market determinants which are stimulating the global protein crystallization market. 
• Detailed and extensive market segments with regional distribution of forecast revenues. 
• Extensive profiles and recent developments of market players. 
Companies Mentioned 
1. Agilent Technologies, Inc. 
2. Anton Paar GmbH 
3. Art Robbins Instruments, LLC. 
4. Bruker Corp. 
5. Charles River Laboratories, Inc. 
6. Creative Biostructure 
7. Crelux GmbH 
8. Formulatrix, Inc. 
9. GE Healthcare 
10. Hampton Research Corp. 
11. Jena Bioscience GmbH 
12. Mitegen, LLC 
13. Molecular Dimensions Ltd. 
14. Novoprotein Scientific Inc. 
15. Proteros Biostructures GmbH 
16. Rigaku Corp. 
17. SARomics Biostructures AB 
18. Shamrock Structures, LLC. 
19. Shanghai Medicilon, Inc. 
20. Thermo Fisher Scientific, Inc.

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
8411985042
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Non-alcoholic Steatohepatitis Biomarkers Market 2019 Global Analysis & Forecast to 2023 Market Research Report

New Study On “2019-2023 Non-alcoholic Steatohepatitis Biomarkers Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast”

PUNE , MAHARASHTRA, INDIA, March 19, 2019 /EINPresswire.com/ — Global Non-alcoholic Steatohepatitis Biomarkers Industry

New Study On “2019-2023 Non-alcoholic Steatohepatitis Biomarkers Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

Non-alcoholic Steatohepatitis (NASH) is a type of NAFLD (Non-alcoholic fatty liver disease), a condition in which fat develops in the liver. NASH normally develops in patients affected with one of the conditions, including dyslipidemia, glucose intolerance, and obesity. To detect NASH disease, some invasive and non-invasive methods are available which include liver biopsy, imaging technology, and biomarkers. Biomarkers are considered one of the non-invasive techniques for the diagnosis of NASH among patients. Several non-invasive biomarkers and panels have been tested with an objective to determine liver fibrosis. For instance, Enhanced liver fibrosis (ELF) and NASH FibroSure are certain panels used to test for liver fibrosis.

Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/3739561-global-non-alcoholic-steatohepatitis-biomarkers-market-forecast-2018-2023

Moreover, there are several factors boosting the global NASH biomarkers market, including increasing funding for NASH detection techniques. For instance, in November 2017, GENFIT SA has contributed to around $39 million in the LITMUS initiative, led by the two-joint undertaking of European Innovative Medicines Initiative (IMI) for the development of non-invasive biomarkers. This aimed to develop new and effective biomarkers for better diagnosis of patients having affected with NAFLD. In addition, it enables to identify those who are at higher risk of developing critical inflammation and liver scarring. It represents the growing focus of European government and companies towards developing more accurate diagnostic biomarkers for NASH detection. This, in turn, accelerates the demand for NASH biomarkers and enables the market to grow across the globe. Additionally, NASH programs in the US & Europe and increasing partnerships to develop NASH biomarkers are further contributing towards the market growth. However, high capital investment and availability of substitute such as imaging technology are restricting the growth of NASH biomarkers market.

The global non-alcoholic steatohepatitis biomarkers market is further analyzed on the basis of the geographical regions, which includes North America, Europe, Asia-Pacific, and Rest of the World, that are significantly contributing towards the growth of the market. Europe and North America are expected to hold a significant share in the global NASH biomarkers market due to increasing awareness programs and significant funding provided by the government organizations and pharmaceutical companies. Moreover, the presence of major players in these regions is further leveraging the market growth in these regions. Asia-Pacific is anticipated to witness the fastest growth rate in the global NASH biomarkers during the forecast period. This is majorly due to increasing awareness of chronic liver conditions in the region. 
Some of the key vendors operating in the global NASH biomarkers market are Thermo Fisher Scientific, Inc., GENFIT SA, Nordic Bioscience, Siemens Healthcare GmbH, OWL Metabolomics, and Gilead Sciences, Inc., among others. Mergers & acquisitions and partnerships adopted by these players to be competitive in the market. For example, in June 2017, OWL Metabolomics and ProSciento partnered to set up a database of potential clinical study participants that are assessed for the presence of NAFLD and NASH with the use of OWL’s lipidomics-based and non-invasive diagnostic assays. This is expected to improve the identification of people having NASH and NAFLD by utilizing non-invasive blood tests. 
Research methodology 
The market study of global non-alcoholic steatohepatitis biomarkers market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports. 
Secondary sources include 
• Financial reports of companies involved in the market 
• Authentic Public Databases such as National Institutes of Health (NIH), among others. 
• Whitepapers, research-papers, and news blogs 
• Company websites and their product catalog 
The report is intended for government and private companies for overall market analysis and competitive analysis. The report provides in-depth analysis of pricing, market size, intended quality of the product preferred by consumers and initial norms. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models. 
Market segmentation 
Global NASH biomarkers market is segmented on the basis of regional outlook and following segments: 
1. Global NASH Biomarkers Market Research and Analysis by Biomarker Type 
2. Global NASH Biomarkers Market Research and Analysis by End-users 
3. Global NASH Biomarkers Market Research and Analysis by Region 

For Detailed Reading Please visit WiseGuy Reports @  https://www.wiseguyreports.com/reports/3739561-global-non-alcoholic-steatohepatitis-biomarkers-market-forecast-2018-2023

The report covers 
• Comprehensive research methodology of the global non-alcoholic steatohepatitis biomarkers market. 
• This report also includes a detailed and extensive market overview with key analyst insights. 
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. 
• Analysis of regional regulations and other government policies impacting the global non-alcoholic steatohepatitis biomarkers market. 
• Insights about market determinants which are stimulating the global non-alcoholic steatohepatitis biomarkers market. 
• Detailed and extensive market segments with regional distribution of forecasted revenues. 
• Extensive profiles and recent developments of market players. 
Companies Mentioned 
1. Allergan PLC 
2. ALPCO 
3. Antaros Medical AB 
4. BioPredictive S.A.S 
5. Boehringer Ingelheim International GmbH 
6. Bristol-Myers Squibb Co. 
7. Covance Inc. 
8. Enterome SA 
9. GENFIT SA 
10. Gilead Sciences, Inc. 
11. Laboratory Corporation of America Holdings 

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
8411985042
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Global Bioreactors Market 2019 Share, Trend, Segmentation and Forecast to 2023

New Study On “2019-2023 Bioreactors Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

PUNE , MAHARASHTRA, INDIA, March 19, 2019 /EINPresswire.com/ — Global Bioreactors Industry

New Study On “2019-2023 Bioreactors Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

The bioreactors are used for growing organisms such as yeast, bacteria, or animal cells in a biologically active environment. With the growing life science industry globally, bioreactors are extensively being used in the production of monoclonal antibodies, recombinant therapeutics, drug discovery and so forth. Bioreactors enable the control over temperature, moisture, pH, oxygen, and stirring rate for optimal cell growth and productivity. The factors contributing to the growth of the market are the growing technological advancements in bioreactor design, growing demand for therapeutically effective vaccines, and new product in development. 
Increasing demand for personalized medicine for effective treatment is one of the major reasons for the growth of this market. The development of precision medicine that is modifying the medical treatment to the individual characteristics, needs, and preferences of each patient has seen positive growth. This is augmenting the demand for bioreactors in medical facilities. Additionally, the increasing capabilities of contract manufacturing organizations (CMOs) to meet the growing demand of the biopharmaceutical and bioprocessing industry will drive the growth of the market. However, challenges associated with the use of bioreactors such as non-customizable and difficult to scale may hinder the global bioreactor market growth. Though, increasing adoption of single-use bioreactor joined with technological innovation and enhanced capabilities are expected significantly contribute in the near future.

Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/3739560-global-bioreactors-market-research-and-forecast-2018-2023

The global bioreactor market is analyzed on the basis of the geographical regions that are contributing significantly towards the growth of the market. North America dominates the market for bioreactors followed by Europe. North America is leading the market in terms of revenue owing to the presence of leading industry players and increasing healthcare expenditure in this region. Further, extensive technological advancement in the field of bioprocess equipment will drive the growth of the bioreactor market in the North American Region. Asia-Pacific is expected to be the fastest growing market due to the increasing adoption of advanced bioreactors by CROs to increase their manufacturing capabilities. Countries such as China and India are significantly contributing in the bioreactor market during the forecast period. China bioreactor market is expected to be a major country due to rising R&D investment, and government initiatives to boost the growth of the market. Some of the major players in the bioreactor market include Thermo Fisher Scientific, Inc., PBS Biotech, Inc., Applikon, Biotechnology B.V., bbi Biotech GmbH, General Electric Company, Pierre Guerin SAS and so forth. 
Research methodology 
The market study of bioreactors market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity in our reports. 
Secondary sources include 
• Financial reports of companies involved in the market 
• Authentic Public Databases 
• Whitepapers, research-papers, and news blogs 
• Company websites and their product catalog 
The report is intended for drug manufacturers, healthcare provider, government organizations for overall market analysis, and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions. 
Market segmentation 
1. Global Bioreactor Market Research and Analysis by Type 
2. Global Bioreactor Market Research and Analysis by Application 
3. Global Bioreactor Market Research and Analysis by End-User 

For Detailed Reading Please visit WiseGuy Reports @  https://www.wiseguyreports.com/reports/3739560-global-bioreactors-market-research-and-forecast-2018-2023

The report covers 
• Comprehensive research methodology of the global bioreactors market. 
• This report also includes a detailed and extensive market overview with Analyst insights & key market trends.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. 
• Analysis of regional regulations and other government policies impacting the global bioreactors market. 
• Insights about market determinants which are stimulating the global bioreactors market. 
• Detailed and extensive market segments with regional distribution of forecasted revenues. 
• Recent developments of market players and extensive profiles. 
Companies Mentioned 
1. Andel Equipment Pvt. Ltd. 
2. Applikon Biotechnology B.V. 
3. Lianyungang Bailun Bio-technology Co., Ltd. 
4. bbi-biotech GmbH 
5. Bellco Glass, Inc. 
6. Bioengineering AG 
7. Cellexus, Ltd. 
8. CerCell ApS 
9. CESCO Bioengineering Co. Ltd. 
10. General Electric Co. 
11. GEA Group Aktiengesellschaft 
12. LAMBDA CZ, s.r.o. 
13. medorex e.K. 
14. Merck KGaA, 
15. Pall Corp. 
16. PBS Biotech, Inc. 
17. PIERRE GUERIN SAS 
18. Sartorius Corporate Administration GmbH 
19. Solaris Biotechnology SRL 
20. Techniserv, Inc. 
21. Thermo Fisher Scientific, Inc. 
22. Zenith Engineers

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
8411985042
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Orthopedic Tapes Market: Global Industry Analysis and Opportunity Assessment, 2019 – 2025

New Study On “2018-2025 Orthopedic Tapes Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

PUNE , MAHARASHTRA, INDIA, March 19, 2019 /EINPresswire.com/ — Global Orthopedic Tapes Industry

New Study On “2018-2025 Orthopedic Tapes Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

The report covers the analysis and forecast of a Orthopedic Tapes on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (US$ Mn). 
The study provides a detailed view of the orthopedic tapes market, by segmenting it based on product type, by material type, by end- user and regional demand. Robust, rising rates of wound infection and injuries in the past several years propels the growth of the orthopedic tapes market. Increasing adoption of orthopedic tapes in healthcare, homecare and other sectors is another prime factor driving the market demand of orthopedic products. Additionally, the growth of geriatric population across the globe is one of the major factor for making the market more demanding over the projection period. 
Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The segmentation also includes by product type, by material, by application, and by end-users in all regions. These include different business strategies adopted by the leading players and their recent developments.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/3289656-global-orthopedic-tapes-market-by-product-type-orficast

A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the orthopedic tapes at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the orthopedic tapes market.

The report provides the size of the orthopedic tapes market in 2017 and the forecast for the next nine years up to 2025. The size of the global orthopedic tapes market is provided in terms of revenue. Market revenue is defined in US$ Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been taken into account in estimating the growth of the global market.

Market estimates for this study have been based on revenue being derived through regional pricing trends. The orthopedic tapes has been analyzed based on expected demand. We have used the bottom-up approach to estimate the global revenue of the orthopedic tapes, split into regions. Based on, product type, material type, by application, and by end-user we have summed up the individual revenues from all the regions to achieve the global revenue for orthopedic tapes. Companies were considered for the market share analysis, based on their innovation and material and revenue generation. In the absence of specific data related to the sales of orthopedic tapes product several privately held companies, calculated assumptions have been made in view of the company’s penetration and regional presence.

The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include B. Braun Melsungen AG, Cardinal Health Inc., Derma Sciences Inc., Johnson & Johnson, Molnlycke Health Care AB, Medtronic, Medline Industries, Paul Hartmann AG, and Zimmer Biomet. 
The global orthopedic tapes has been segmented into: 
Global Orthopedic Tapes Market: By Product Type 
• Orficast 
• Cellona plaster- of- paris 
• Delta- lite plus 
• Cellacast xrta cast tapes 
• Techform premium 
• Others 
Global Orthopedic Tapes Market: By Material Type 
• Plastic 
• Fabric 
• Elastic 
• Others 
Global Orthopedic Tapes Market: By Application 
• Surgical wound treatment 
• Burn injury 
• Traumatic wound treatment 
• Sports injury 
• Others 
Global Orthopedic Tapes Market: By End-user 
• Healthcare center 
• Homecare 
• Ambulatory surgery center 
Global Orthopedic Tapes Market: By Geography 
• North America 
o U.S. 
o Canada 
o Mexico 
• Europe 
o U.K. 
o France 
o Germany 
o Italy 
o Rest of Europe 
• Asia Pacific 
o India 
o China 
o Japan 
o Rest of Asia Pacific 
• Middle East and Africa 
o South Africa 
o Rest of Middle East and Africa 
• Latin America 
o Brazil 
o Rest of Latin America

For Detailed Reading Please visit WiseGuy Reports @     https://www.wiseguyreports.com/reports/3289656-global-orthopedic-tapes-market-by-product-type-orficast

Some Major Points from Table of content:

1 INTRODUCTION 
    1.1 MARKET SEGMENTATION 
2 RESEARCH METHODOLOGY 
    2.1 TOP-DOWN APPROACH 
    2.2 BOTTOM-UP APPROACH 
    2.3 ASSUMPTIONS 
3 EXECUTIVE SUMMARY 
    3.1 GLOBAL ORTHOPEDIC TAPES MARKET SNAPSHOT 
    3.2 GLOBAL ORTHOPEDIC TAPES MARKET REVENUE, 2017– 2025(US$ MN) 
4 MARKET OVERVIEW 
    4.1 INTRODUCTION 
    4.2 KEY TRENDS ANALYSIS 
    4.3 PRODUCT TYPE DEVELOPMENT AND DIVERSIFICATION ANALYSIS 
    4.4 PORTERS FIVE FORCE ANALYSIS 
    4.5 VALUE CHAIN ANALYSIS 
    4.6 COMPETITIVE LANDSCAPE 
    4.7 COMPANY MARKET SHARE ANALYSIS 
    4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS 
5 GLOBAL ORTHOPEDIC TAPES , BY PRODUCT TYPE 
    5.1 OVERVIEW 
    5.2 ORFICAST 
    5.3 CELLONA PLASTER- OF- PARIS 
    5.4 DELTA- LITE PLUS 
    5.5 CELLACAST XRTA CAST TAPES 
    5.6 TECHFORM PREMIUM 
    5.7 OTHERS 
6 GLOBAL ORTHOPEDIC TAPES , BY MATERIAL TYPE 
    6.1 OVERVIEW 
    6.2 PLASTIC 
    6.3 FABRIC 
    6.4 ELASTIC 
    6.5 OTHERS 
7 GLOBAL ORTHOPEDIC TAPES MARKET, BY APPLICATION 
    7.1 SURGICAL WOUND TREATMENT 
    7.2 BURN INJURY 
    7.3 TRAUMATIC WOUND TREATMENT 
    7.4 SPORTS INJURY 
    7.5 OTHERS 
8 GLOBAL ORTHOPEDIC TAPES MARKET, BY END-USER 
    8.1 OVERVIEW 
    8.2 HEALTHCARE CENTER 
    8.3 HOMECARE 
    8.4 AMBULATORY SURGERY CENTER 
9 GLOBAL ORTHOPEDIC TAPES MARKET, BY GEOGRAPHY 
    9.1 NORTH AMERICA 
      9.1.1 MARKET DYNAMICS 
          9.1.1.1 DRIVERS 
          9.1.1.2 RESTRAINTS 
          9.1.1.3 OPPORTUNITY 
      9.1.2 U.S. 
      9.1.3 CANADA 
      9.1.4 MEXICO 
    9.2 EUROPE 
      9.2.1 MARKET DYNAMICS 
          9.2.1.1 DRIVERS 
          9.2.1.2 RESTRAINTS 
          9.2.1.3 OPPORTUNITY 
      9.2.2 U.K. 
      9.2.3 FRANCE 
      9.2.4 GERMANY 
      9.2.5 SPAIN 
      9.2.6 REST OF EUROPE 
    9.3 ASIA PACIFIC 
      9.3.1 MARKET DYNAMICS 
          9.3.1.1 DRIVERS 
          9.3.1.2 RESTRAINTS 
          9.3.1.3 OPPORTUNITY 
      9.3.2 INDIA 
      9.3.3 CHINA 
      9.3.4 JAPAN 
      9.3.5 REST OF ASIA PACIFIC 
    9.4 MIDDLE EAST AND AFRICA 
      9.4.1 MARKET DYNAMICS 
          9.4.1.1 DRIVERS 
          9.4.1.2 RESTRAINTS 
          9.4.1.3 OPPORTUNITY 
      9.4.2 SOUTH AFRICA 
      9.4.3 REST OF MIDDLE EAST AND AFRICA 
    9.5 LATIN AMERICA 
      9.5.1 MARKET DYNAMICS 
          9.5.1.1 DRIVERS 

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
8411985042
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Intraocular Lens Market: Global Industry Analysis and Opportunity Assessment, 2019 – 2025

New Study On “2018-2025 Intraocular Lens Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

PUNE , MAHARASHTRA, INDIA, March 19, 2019 /EINPresswire.com/ — Global Intraocular Lens Industry

New Study On “2018-2025 Intraocular Lens Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database

The report covers the analysis and forecast of the intraocular lens market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (US$ Mn).

Th e study provides a detailed view of the Intraocular Lens market, by segmenting it based on by product type, material, end- user, and regional demand. Growing adoption of premium intraocular lens in the past several years propels the growth for the intraocular lens market. Moreover, increasing prevalence of catarac across the globe are the prime factor driving the market demand. Aditionally, government initiatives for eliminating the avoidable blindness are expected to fuels the demand for the global intraocular lens market in the near future.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/3289661-global-intraocular-lens-market-by-product-type-monofocal

Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The segmentation also includes by product type, and by material, by end- user in all regions. These include different business strategies adopted by the leading players and their recent developments.

A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the intraocular lens market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the intraocular lens market.

The report provides the size of the intraocular lens market in 2017 and the forecast for the next eight years up to 2025. The size of the global intraocular lens market is provided in terms of revenue. Market revenue is defined in US$ Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been taken into account in estimating the growth of the global market.

Market estimates for this study have been based on revenue being derived through regional pricing trends. The intraocular lens market has been analyzed based on expected demand. Bottom-up approach is done to estimate the global revenue of the Intraocular Lens market, split into regions. Based on product type, material, end- user the individual revenues from all the regions is summed up to achieve the global revenue for intraocular Lens. Companies were considered for the market share analysis, based on their innovation and product type and revenue generation. In the absence of specific data related to the sales of intraocular lens several privately held companies, calculated assumptions have been made in view of the company’s penetration and regional presence.

The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include Alcon (A Novartis AG Division), Carl Zeiss Meditec AG, Eyekon Medical Inc., Humanoptics AG, Hoya Corporation, Johnson & Johnson, Lenstec Inc., Rayner Intraocular Lenses Ltd., and Staar Surgical Company.
The global Intraocular Lens market has been segmented into:
Global Intraocular Lens Market: By Product Type
• Monofocal intraocular lens
• Multifocal intraocular lens
• Toric intraocular lens
• Phakic intraocular lens
• Others
Global Intraocular Lens Market: By Material
• Silicone
• Polymethylmethacrylate (pmma)
• Hydrophobic acrylic
Global Intraocular Lens Market: By End- User
• Eye research institutes
• Ophthalmology clinics
• Others
Global Intraocular Lens Market: By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o France
o Germany
o Italy
o Rest of Europe
• Asia Pacific
o India
o China
o Japan
o Rest of Asia Pacific
• Middle East and Africa
o South Africa
o Rest of Middle East and Africa
• Latin America
o Brazil
o Rest of Latin America 

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3289661-global-intraocular-lens-market-by-product-type-monofocal

Some Major Points from Table of content:

1 RESEARCH METHODOLOGY, ASSUMPTIONS AND ACRONYMS
2 EXECUTIVE SUMMARY
2.1 GLOBAL INTRAOCULAR LENS MARKET
3 GLOBAL INTRAOCULAR LENS MARKET-MARKET OVERVIEW
3.1 INTRODUCTION
3.1.1 GLOBAL INTRAOCULAR LENS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
3.1.2 GLOBAL INTRAOCULAR LENS MARKET SNAPSHOT
4 GLOBAL INTRAOCULAR LENS MARKET OVERVIEW- BY PRODUCT TYPE
4.1 INTRODUCTION
4.1.1 GLOBAL INTRAOCULAR LENS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY PRODUCT TYPE
4.1.1.1 MONOFOCAL INTRAOCULAR LENS
4.1.1.2 MULTIFOCAL INTRAOCULAR LENS
4.1.1.3 TORIC INTRAOCULAR LENS
4.1.1.4 PHAKIC INTRAOCULAR LENS
4.1.1.5 OTHERS
5 GLOBAL INTRAOCULAR LENS MARKET ANALYSIS AND FORECAST, BY MATERIAL
5.1 INTRODUCTION
5.1.1 GLOBAL INTRAOCULAR LENS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY MATERIAL
5.1.1.1 SILICONE
5.1.1.2 POLYMETHYLMETHACRYLATE (PMMA
5.1.1.3 HYDROPHOBIC ACRYLIC
6 GLOBAL INTRAOCULAR LENS MARKET ANALYSIS AND FORECAST, BY END- USER
6.1 INTRODUCTION
6.1.1 GLOBAL INTRAOCULAR LENS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY END- USER
6.1.1.1 EYE RESEARCH INSTITUTES
6.1.1.2 OPHTHALMOLOGY CLINICS
7 GLOBAL INTRAOCULAR LENS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET, BY REGION
7.1 INTRODUCTION
7.2 KEY TAKEWAYS
8 NORTH AMERICA INTRAOCULAR LENS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
8.1 MARKET DYNAMICS
8.1.1 DRIVERS
8.1.2 RESTRAINTS
8.1.3 OPPORTUNITIES
8.2 NORTH AMERICA INTRAOCULAR LENS MARKET ANALYSIS- BY PRODUCT TYPE
8.3 NORTH AMERICA INTRAOCULAR LENS MARKET ANALYSIS- BY MATERIAL
8.4 NORTH AMERICA INTRAOCULAR LENS MARKET ANALYSIS- BY END- USER
8.5 U.S.
8.6 CANADA
8.7 MEXICO
9 EUROPE INTRAOCULAR LENS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
9.1 MARKET DYNAMICS
9.1.1 DRIVERS
9.1.2 RESTRAINTS
9.1.3 OPPORTUNITIES
9.2 EUROPE INTRAOCULAR LENS MARKET ANALYSIS- BY PRODUCT TYPE
9.3 EUROPE INTRAOCULAR LENS MARKET ANALYSIS- BY MATERIAL
9.4 EUROPE INTRAOCULAR LENS MARKET ANALYSIS- BY END- USER
9.5 U.K.
9.6 FRANCE
9.7 GERMANY
9.8 ITALY
9.9 SPAIN
9.10 REST OF EUROPE
10 ASIA PACIFIC INTRAOCULAR LENS MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
10.1 MARKET DYNAMICS
10.1.1 DRIVERS
10.1.2 RESTRAINTS

Norah Trent
WISEGUY RESEARCH CONSULTANTS PVT LTD
8411985042
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Global Cold Remedies 2019 Trends, Supply, Care, Analysis & Forecast to 2025

Wise.Guy12

Wise.Guy.

Wiseguyreports.Com Adds “Global Cold Remedies Market Research Report 2019" To Its Research Database

PUNE, MAHARASTRA, INDIA, March 19, 2019 /EINPresswire.com/ — Summary

Wiseguyreports.Com Adds “Global Cold Remedies Market Research Report 2019" To Its Research Database

Cold Remedies Market 2025

Description: –

Cold is an infectious disease that affects the respiratory system. The common symptoms for cold include sneezing, sore throat, a stuffy nose, and coughing. Cold remedies are used to treat cold in immunosuppressed individuals.

The composition of many cold medicines are same and therefore taking too much of certain medication can lead to drug resistance or serious injury.

Scope of the Report:

The global Cold Remedies market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Cold Remedies volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cold Remedies market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

Free Sample Report @ https://www.wiseguyreports.com/sample-request/3832349-global-cold-remedies-market-research-report-2019

The major manufacturers covered in this report

Reckitt Benckiser Group
Johnson & Johnson
GlaxoSmithKline
Novartis
Bayer
AstraZeneca
Sun Pharmaceutical Industries
Pfizer
Prestige Brands Holdings
Procter & Gamble

Segment by Regions
North America
Europe
China
Japan

Segment by Type
By drug type
Antihistamines
Expectorants
Bronchodilators
Decongestants
Antibiotics
Others

By dosage type
Antihistamines
Expectorants
Bronchodilators
Decongestants
Antibiotics
Others

Segment by Application
Antihistamines
Expectorants
Bronchodilators
Decongestants
Antibiotics
Others

For Detailed Report @ https://www.wiseguyreports.com/reports/3832349-global-cold-remedies-market-research-report-2019

Major Key Points in Table of Content:

1 Cold Remedies Market Overview
1.1 Product Overview and Scope of Cold Remedies
1.2 Cold Remedies Segment By drug type
1.2.1 Global Cold Remedies Production Growth Rate Comparison By drug type (2014-2025)
1.2.2 Antihistamines
1.2.3 Expectorants
1.2.4 Bronchodilators
1.2.5 Decongestants
1.2.6 Antibiotics
1.2.7 Others
1.3 Cold Remedies Segment by Application
1.3.1 Cold Remedies Consumption Comparison by Application (2014-2025)
1.3.2 Antihistamines
1.3.3 Expectorants
1.3.4 Bronchodilators
1.3.5 Decongestants
1.3.6 Antibiotics
1.3.7 Others
1.4 Global Cold Remedies Market by Region
1.4.1 Global Cold Remedies Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Cold Remedies Market Size
1.5.1 Global Cold Remedies Revenue (2014-2025)
1.5.2 Global Cold Remedies Production (2014-2025)

2 Global Cold Remedies Market Competition by Manufacturers
2.1 Global Cold Remedies Production Market Share by Manufacturers (2014-2019)
2.2 Global Cold Remedies Revenue Share by Manufacturers (2014-2019)
2.3 Global Cold Remedies Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Cold Remedies Production Sites, Area Served, Product Types
2.5 Cold Remedies Market Competitive Situation and Trends
2.5.1 Cold Remedies Market Concentration Rate
2.5.2 Cold Remedies Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

…………….

7 Company Profiles and Key Figures in Cold Remedies Business
7.1 Reckitt Benckiser Group
7.1.1 Reckitt Benckiser Group Cold Remedies Production Sites and Area Served
7.1.2 Cold Remedies Product Introduction, Application and Specification
7.1.3 Reckitt Benckiser Group Cold Remedies Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Cold Remedies Production Sites and Area Served
7.2.2 Cold Remedies Product Introduction, Application and Specification
7.2.3 Johnson & Johnson Cold Remedies Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Cold Remedies Production Sites and Area Served
7.3.2 Cold Remedies Product Introduction, Application and Specification
7.3.3 GlaxoSmithKline Cold Remedies Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Novartis
7.4.1 Novartis Cold Remedies Production Sites and Area Served
7.4.2 Cold Remedies Product Introduction, Application and Specification
7.4.3 Novartis Cold Remedies Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Bayer
7.5.1 Bayer Cold Remedies Production Sites and Area Served
7.5.2 Cold Remedies Product Introduction, Application and Specification
7.5.3 Bayer Cold Remedies Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 AstraZeneca
7.6.1 AstraZeneca Cold Remedies Production Sites and Area Served
7.6.2 Cold Remedies Product Introduction, Application and Specification
7.6.3 AstraZeneca Cold Remedies Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Sun Pharmaceutical Industries
7.7.1 Sun Pharmaceutical Industries Cold Remedies Production Sites and Area Served
7.7.2 Cold Remedies Product Introduction, Application and Specification
7.7.3 Sun Pharmaceutical Industries Cold Remedies Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served

Continued……

Leave a Query @ https://www.wiseguyreports.com/enquiry/3832349-global-cold-remedies-market-research-report-2019

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}


Source: EIN Presswire

Certified CannabisTest Kits Can Ensure Consistent Results at a realistic price, sold for over 10 years with great success

Certified World Wide,Thin Layer Chromatography Cannabis testing kits and supplies easy to use,compare your results with any GC or HPLC testing machines

MEDFORD, OR, 97504, March 19, 2019 /EINPresswire.com/ — How Mobile Cannabis Test Kits Can Ensure Consistent Results at a realistic price, By TLC Lab Supply sold for over 10 years with great success

Cannabis testing has been largely adopted by laboratories and many workplaces to make sure safe and healthy environments. With mobile cannabis test kits coming into life by TLC Lab Supply, this has become easier than ever, and at only $8.00 usd per test or less you just can not due any better, and they work.

With using mobile cannabis test kits manufactured and supplied by TLC Lab Supply, the cannabis testing process for business is done most effectively and with a confidential manner to find accurate potency results. Cannabis is one of the highly consumed drugs worldwide and hence having a cannabis test kit near you for this becomes an absolute necessity. In fact, people choose to buy cannabis test kits for home use just in case they don’t want to go for public testing.

Unfortunately, the use of cannabis is still frowned upon in many places and can cause work loss and the person’s social, professional as well as economic status. When it comes to reliability and accuracy, cannabis test kits by TLC Lab Supply win points at many levels. Though a lot of people believe that no CBD, THC test kit can be accurate, our products can prove the notion entirely wrong since they actually produce exact potency percentage details present in cannabis plant material and products.

There is a myriad of cannabis testing kits available, but there’s no comparison to TLC Lab Supply cannabis test kits because of being absolutely specific and correct every time used. This is why our cannabis testing kits are #1 choice for healthcare, labs, hospitals and other institutions all over the world.

Advantages of Buying Cannabis Test Kits from TLC Lab Supply

Cannabis test kits of high-quality offered by TLC Lab Supply are unlike those convoluted test kits which become a headache to use in a proper manner. At TLC Lab Supply, we present you a simple and efficient test kit for cannabis which can be used further with absolute ease. You don’t need any major guidance for it to use. All you need to do is to follow the given instruction and make use of it accordingly.

TLC Lab Supply offered cannabis test kits are available in different sizes and at a competitive price compared to most labs. Thus, if you are in search of a cannabis test kit within a certain budget; have a leap of faith with our THC, CBD, CBN, CBG test kits i.e. worldwide compliant, sold worldwide on a daily bases

Our offered marijuana home test kits can be used as well in medical labs since it complies fully with the world health organization, FDA, USP, cGMP, and Canada TK compliant. When it comes to generating accurate results, our cannabis test kits are absolutely a reliable product. Rest assured that results can be compared to any accurately run GC or HPLC lap machines.

Want to discover how much potency your cannabis plant materials and products have? Visit: https://www.thctestkits.com for a ton of information and a instructional video

Roger Green
TLC Lab Supply
+15416901000
email us here
Visit us on social media:
Facebook
Twitter
Google+
LinkedIn

Instructional Video for testing cannabis with thin layer chromatography ( TLC ) testing


Source: EIN Presswire

Foam Swab Manufacturer Super Brush LLC Will Be Exhibiting at Foam Expo

Super Brush LLC 800 Worcester St Springfield, MA 01151

Super Brush Foam Swabs

Visit Super Brush at Foam Expo 2019 Booth 814

Super Brush LLC will be exhibiting at this year’s Foam Expo in Novi, Michigan

The Foam Expo gives our team the opportunity interact with many of our suppliers in the foam industry and explore new technologies.”

— Sales Manager, Diane Henry

SPRINGFIELD, MASSACHUSETTS, UNITED STATES, March 18, 2019 /EINPresswire.com/ — Super Brush LLC will be exhibiting at this year’s Foam Expo in Novi, Michigan. This year’s show has over 350 exhibitors, 60 speakers, and plans to have over 6,000 attendees. The Foam Expo brings manufacturers and buyers of foam from all over the United States and the globe. Whether you want to hear about raw materials, supply chain, chemicals, or manufacturer and process equipment, Foam Expo has something to offer.

From prototype to full-scale production, Super Brush has the in-house resources have the ability to engineer durable, lint-free foam swabs. Super Brush designs machinery for feeding, forming, and sealing foam to achieve a highly automated production process. To ensure the highest quality products are produced, Super Brush employs vision systems to identify foam abnormalities Super Brush’s quality system is certified to ISO 13485:2016 and the manufacturing facility is FDA registered.

“The Foam Expo gives our team the opportunity interact with many of our suppliers in the foam industry and explore new technologies. This year, we look forward to seeing current and prospective customers who are attending to learn about the new innovations in the industry,” explains Diane Henry, Super Brush’s Director of Sales.

Super Brush will be showing wide range of foam applicators and swabs, including Swab-its Firearm Cleaning Products, at booth 814. For more information about foam expo visit http://www.foam-expo.com/.

About Super Brush LLC

The American company, Super Brush LLC, is a leading manufacturer of foam swabs. Super Brush engineers foam swabs and applicators for leading organizations across the industrial, medical, aerospace, printer, firearm, and other industries. The scale, scope, and knowledge of foam swab technology and applications allow Super Brush to address and custom design solutions as others cannot. Find our Super Brush products through our website www.superbrush.com.

Michael Lecrenski
Super Brush LLC
+1 413-543-1442
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Health Care Professionals: Become Part of the Climate Change Solution at MGH Institute of Health Professions Symposium

The Center is the first-of-its-kind, nurse-led initiative created to address ways all health care professionals can respond to the impact of climate change

Several experts, including former EPA administrator Gina McCarthy, will discuss ways to help patients at April 6 event in Boston.

BOSTON, MA, USA, March 18, 2019 /EINPresswire.com/ — Each day, health care professionals help patients whose lives are impacted by climate change because of poor air quality, nutrition and food insecurity, food-, water-, and vector-borne diseases, mental health issues, and much more. These issues disproportionately affect low-income individuals, some communities of color, and those with higher vulnerability to disease and chronic health conditions.

And it’s only going to get worse unless something’s done, and quickly.

Health practitioners can discover ways to leverage their influence and expertise to support the transition to climate-smart healthcare through advocacy, education, research, and clinical practice on April 6 at “Reducing the Impact of Climate Change on Health: The Role of Health Care Professionals,” a day-long symposium held on the campus of MGH Institute of Health Professions in Boston.

Gina McCarthy, former US Environmental Protection Agency (EPA) administrator from 2013-2017 in the Obama Administration and currently the director of the Center for Climate, Health, and the Global Environment at Harvard University’s T.H. Chan School of Public Health, is the event’s keynote speaker. Her talk will be followed by several health care experts who will lead the audience in robust discussions leading to tangible steps to improve the lives of patients. These discussions will include identifying the risks of health climate change, advocating for climate/environmental justice, and mitigating the impact of climate change on health and well-being.

The symposium is presented by the MGH Institute of Health Professions' Center for Climate Change, Climate Justice, and Health – the first-of-its-kind, nurse-led initiative created to address ways all health care professionals can respond to the impact of climate change. The Center’s eleven faculty members have published books and articles on climate change and presented at national and international conferences.

John Shaw
MGH Institute of Health Professions
+1 617-726-4276
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire